QT Imaging Holdings, Inc. key statistics and ratios
In fiscal 2025, QT Imaging Holdings, Inc. had an operating margin of -23.4%, debt equal to 156.9% of equity and a current ratio of 2.81. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|
| Gross margin | — | — | 54.1% | 45.4% | 40.4% |
| Operating margin | — | <−999% | −249.6% | −23.4% | −24.8% |
| Net margin | — | <−999% | −184.2% | −111.4% | −77.3% |
| Free-cash-flow margin | — | <−999% | −207.4% | −48.0% | −48.2% |
| Return on assets | −6.6% | −25.1% | −140.5% | −144.9% | −76.1% |
| Asset turnover | — | 0.00 | 0.76 | 1.30 | 0.99 |
| Current ratio | 0.06 | 0.66 | 0.50 | 2.81 | 3.10 |
| Debt to equity | — | — | — | 156.9% | 507.4% |
| Interest cover (operating income ÷ interest) | n/m | n/m | — | — | — |
| R&D as % of revenue | — | >999% | 67.0% | 20.8% | 20.9% |
| SG&A as % of revenue | — | >999% | 236.7% | 48.0% | 44.3% |
| Capital spending as % of revenue | — | 32.3% | 1.8% | 0.7% | 1.0% |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 63.3% | 47.2% | 64.8% | 49.9% | 43.0% | 38.0% | 40.9% | 41.2% |
| Operating margin | −243.4% | −242.2% | −37.2% | −28.5% | −39.4% | −8.5% | −36.0% | −25.1% |
| Net margin | −378.6% | −411.9% | −398.0% | −109.4% | −108.7% | −16.8% | −52.2% | −148.9% |
| Free-cash-flow margin | −194.5% | −151.2% | −126.4% | −40.7% | −21.0% | −38.4% | −56.2% | −67.4% |
| Current ratio | 1.06 | 0.50 | 1.86 | 1.69 | 0.89 | 2.81 | 2.49 | 3.10 |
| Debt to equity | — | — | — | — | — | 156.9% | 265.9% | 507.4% |
| R&D as % of revenue | 96.8% | 91.4% | 30.5% | 24.6% | 22.4% | 15.0% | 26.4% | 21.8% |
| SG&A as % of revenue | 210.0% | 198.0% | 71.6% | 53.8% | 60.0% | 31.4% | 50.5% | 44.4% |
Financial health
- Short-term assets cover short-term liabilities $29m of assets due within a year against $9m of liabilities due within a year.
- Short-term assets cover long-term liabilities $29m short-term assets against $19m of longer-dated liabilities.
- More cash than debt $11m of cash against $11m of debt.
- Debt below 40% of shareholders' equity Debt is 507% of equity.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt −$12m of operating cash flow against $11m of debt.
- Operating profit covers interest at least five times over Interest not separately reported. Not assessable.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.
Compare with peers
- Stereotaxis, Inc. statistics
- Baird Medical Investment Holdings Ltd statistics
- Precision Optics Corporation, Inc. statistics
- Sonoma Pharmaceuticals, Inc. statistics
- Orchestra Biomed Holdings, Inc. statistics
Head to head: QTI vs STXSBDMD vs QTIPOCI vs QTI
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies